Geneos Wealth Management’s Centene CNC Stock Holding History

Geneos Wealth Management’s Portfolio CNC Stock Details CNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.3K	Sell	1,321 -175	-12%	-$7.18K	﹤0.01%	1484
2025 Q4	$61.6K	Hold	1,496	–	–	﹤0.01%	1316
2025 Q3	$53.4K	Sell	1,496 -401	-21%	-$12.1K	﹤0.01%	1365
2025 Q2	$103K	Sell	1,897 -510	-21%	-$29.9K	﹤0.01%	1235
2025 Q1	$220K	Buy	2,407 +1,586	+193%	+$95.8K	﹤0.01%	1188
2024 Q4	$49.7K	Buy	821 +3	+0.4%	+$187	﹤0.01%	1326
2024 Q3	$61.6K	Buy	818 +208	+34%	+$15.2K	﹤0.01%	1128
2024 Q2	$40.4K	Sell	610 -300	-33%	-$21.8K	﹤0.01%	1141
2024 Q1	$71.4K	Sell	910 -302	-25%	-$23.3K	﹤0.01%	951
2023 Q4	$89.9K	Buy	1,212 +52	+4%	+$3.75K	﹤0.01%	870
2023 Q3	$79.9K	Sell	1,160 -5	-0.4%	-$333	﹤0.01%	932
2023 Q2	$78.6K	Hold	1,165	–	–	﹤0.01%	944
2023 Q1	$73.6K	Hold	1,165	–	–	﹤0.01%	941
2022 Q4	$95.5K	Buy	1,165 +602	+107%	+$49.2K	0.01%	838
2022 Q3	$43K	Sell	563 -1,082	-66%	-$96.7K	﹤0.01%	1073
2022 Q2	$141K	Sell	1,645 -69	-4%	-$5.73K	0.01%	882
2022 Q1	$144K	Buy	1,714 +101	+6%	+$8.28K	0.01%	945
2021 Q4	$132K	Sell	1,613 -1,623	-50%	-$119K	0.01%	1065
2021 Q3	$204K	Sell	3,236 -3,861	-54%	-$258K	0.01%	846
2021 Q2	$524K	Buy	7,097 +5,221	+278%	+$358K	0.02%	552
2021 Q1	$115K	Hold	1,876	–	–	﹤0.01%	1231
2020 Q4	$121K	Buy	1,876 +398	+27%	+$25.3K	﹤0.01%	1050
2020 Q3	$81K	Hold	1,478	–	–	﹤0.01%	1034
2020 Q2	$88K	Hold	1,478	–	–	﹤0.01%	974
2020 Q1	$81K	Buy	1,478 +800	+118%	+$48.5K	0.01%	913
2019 Q4	$43K	Hold	678	–	–	﹤0.01%	1330
2019 Q3	$29K	Hold	678	–	–	﹤0.01%	1437
2019 Q2	$35K	Sell	678 -114	-14%	-$6.16K	﹤0.01%	1363
2019 Q1	$42K	Buy	792 +20	+3%	+$1.21K	﹤0.01%	1226
2018 Q4	$43K	Buy	772 +54	+8%	+$3.62K	﹤0.01%	1166
2018 Q3	$51K	Buy	718 +324	+82%	+$22.5K	﹤0.01%	1166
2018 Q2	$24K	Hold	394	–	–	﹤0.01%	1365
2018 Q1	$21K	Hold	394	–	–	﹤0.01%	1366
2017 Q4	$19K	Hold	394	–	–	﹤0.01%	1395
2017 Q3	$19K	Sell	394 -476	-55%	-$20.5K	﹤0.01%	1327
2017 Q2	$34K	Sell	870 -38	-4%	-$1.43K	﹤0.01%	1079
2017 Q1	$32K	Sell	908 -15,342	-94%	-$513K	﹤0.01%	1056
2016 Q4	$459K	Buy	16,250 +15,402	+1,816%	+$454K	0.06%	264
2016 Q3	$28K	Buy	848 +38	+5%	+$1.32K	﹤0.01%	1010
2016 Q2	$28K	Buy	810 +228	+39%	+$7.16K	﹤0.01%	1005
2016 Q1	$17K	Buy	+582	New	+$17.4K	﹤0.01%	1135

Other funds holding CNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geneos Wealth Management's CNC Position: Q1 2026 in Review

Geneos Wealth Management reduced its Centene (CNC) stake by 12% in Q1 2026, selling an estimated $7.18K and leaving 1,321 shares worth $43.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

Geneos Wealth Management first reported a position in CNC in Q1 2016 and has held it in 41 quarters since. The position peaked at $524K in Q2 2021. 862 funds tracked by Wall St. Rank hold CNC as of Q1 2026.

Geneos Wealth Management held 1,321 shares of Centene worth $43.3K as of Q1 2026.
Geneos Wealth Management sold 175 Centene shares in Q1 2026, an estimated $7.18K.
Centene made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1484 holding.
Geneos Wealth Management first reported a position in Centene in Q1 2016 and has held it in 41 quarters since.
Geneos Wealth Management's Centene position peaked at $524K in Q2 2021.
862 funds tracked by Wall St. Rank held Centene as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.